Abstract
Low-cost generic antiretroviral drugs are available in resource-limited settings for treatment of HIV infections. However, few bioequivalence data in specific populations in which these generics are likely to be used are available. We conducted a randomized crossover bioequivalence study of generic and brand name formulations of nevirapine, zidovudine, and lamivudine in HIV-negative Indian women using US Food and Drug Administration (FDA) criteria. Subjects took single doses of all formulations separated by a 14-day washout period. Plasma concentrations were measured over 96 hours during each study period. Average bioequivalence was determined using natural log-transformed maximum concentration (C max) and area-under-the-concentration-time curve (AUC) mean ratio data. Fifteen Indian women were enrolled. The 90% confidence intervals for nevirapine (14 subjects) and lamivudine (15 subjects) C max, AUC from 0 to the last measurable time point (AUC 0-t), and AUC from 0 to infinity (AUC 0-∞) mean ratios and zidovudine (15 subjects) AUC 0-t and AUC 0-∞ mean ratios were all within 0.80 to 1.25. However, the 90% confidence interval for zidovudine C max mean ratio was 0.70 to 1.46. Generic and brand name nevirapine and lamivudine met FDA average bioequivalence criteria. Lack of average bioequivalence for zidovudine was found for C max but is not expected to be clinically significant, because the total AUC values were similar between formulations.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 131-136 |
| Number of pages | 6 |
| Journal | Journal of Acquired Immune Deficiency Syndromes (1999) |
| Volume | 41 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bioequivalence
- Generic antiretrovirals
- Lamivudine
- Nevirapine
- Pharmacokinetics
- Zidovudine
Fingerprint
Dive into the research topics of 'A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS